|
FY2026
12 months to Mar 28, 2026
|
FY2025
12 months to Mar 29, 2025
|
FY2024
12 months to Mar 30, 2024
|
FY2023
12 months to Apr 1, 2023
|
FY2022
12 months to Apr 2, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Deferred income tax expense (benefit) | |||||
| Stock-based compensation expense | |||||
| Impairment of assets | |||||
| Bad debt expense | |||||
| Other non-cash charges | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued liabilities | |||||
| Income tax receivables and payables | |||||
| Operating lease ROU asset and liabilities, net | |||||
| Other balance sheet changes | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Purchases of investments | |||||
| Proceeds from sales and maturities of investments | |||||
| Acquisition of intangible assets | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from the issuance of long-term debt | |||||
| Repayments of long-term debt | |||||
| Payments of finance lease obligations | |||||
| Payments of dividends | |||||
| Repurchases of common stock, including shares surrendered for tax withholdings | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
Loading...